Vaginitis Treatment Drugs Market, Global Outlook and Forecast 2022-2028

August 2022 | 69 pages | ID: V79BB0B29414EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Vaginitis Treatment Drugs in Global, including the following market information:

Global Vaginitis Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vaginitis Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nitroimidazole Compounds Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaginitis Treatment Drugs include Pfizer Inc., Mylan NV, Novartis AS, Bayer AG, Sanofi S.A., Lupin Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd, Cipla Ltd. and Sun Pharmaceutical Industries Limited. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaginitis Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaginitis Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vaginitis Treatment Drugs Market Segment Percentages, by Type, 2021 (%)

• Nitroimidazole Compounds
• Lincosamide Antibiotics
• Triazoles
• Imidazoles

Global Vaginitis Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vaginitis Treatment Drugs Market Segment Percentages, by Application, 2021 (%)

• Bacterial Vaginitis
• Fungal Vaginitis
• Trichomoniasis
• Others

Global Vaginitis Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vaginitis Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaginitis Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vaginitis Treatment Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• Mylan NV
• Novartis AS
• Bayer AG
• Sanofi S.A.
• Lupin Pharmaceuticals, Inc.
• Dr. Reddy's Laboratories Ltd
• Cipla Ltd.
• Sun Pharmaceutical Industries Limited

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vaginitis Treatment Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vaginitis Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VAGINITIS TREATMENT DRUGS OVERALL MARKET SIZE

2.1 Global Vaginitis Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Vaginitis Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vaginitis Treatment Drugs Players in Global Market
3.2 Top Global Vaginitis Treatment Drugs Companies Ranked by Revenue
3.3 Global Vaginitis Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Vaginitis Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vaginitis Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaginitis Treatment Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Vaginitis Treatment Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vaginitis Treatment Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vaginitis Treatment Drugs Market Size Markets, 2021 & 2028
  4.1.2 Nitroimidazole Compounds
  4.1.3 Lincosamide Antibiotics
  4.1.4 Triazoles
  4.1.5 Imidazoles
4.2 By Type - Global Vaginitis Treatment Drugs Revenue & Forecasts
  4.2.1 By Type - Global Vaginitis Treatment Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Vaginitis Treatment Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vaginitis Treatment Drugs Market Size, 2021 & 2028
  5.1.2 Bacterial Vaginitis
  5.1.3 Fungal Vaginitis
  5.1.4 Trichomoniasis
  5.1.5 Others
5.2 By Application - Global Vaginitis Treatment Drugs Revenue & Forecasts
  5.2.1 By Application - Global Vaginitis Treatment Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Vaginitis Treatment Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vaginitis Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Vaginitis Treatment Drugs Revenue & Forecasts
  6.2.1 By Region - Global Vaginitis Treatment Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Vaginitis Treatment Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vaginitis Treatment Drugs Revenue, 2017-2028
  6.3.2 US Vaginitis Treatment Drugs Market Size, 2017-2028
  6.3.3 Canada Vaginitis Treatment Drugs Market Size, 2017-2028
  6.3.4 Mexico Vaginitis Treatment Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vaginitis Treatment Drugs Revenue, 2017-2028
  6.4.2 Germany Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.3 France Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.4 U.K. Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.5 Italy Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.6 Russia Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Vaginitis Treatment Drugs Market Size, 2017-2028
  6.4.8 Benelux Vaginitis Treatment Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vaginitis Treatment Drugs Revenue, 2017-2028
  6.5.2 China Vaginitis Treatment Drugs Market Size, 2017-2028
  6.5.3 Japan Vaginitis Treatment Drugs Market Size, 2017-2028
  6.5.4 South Korea Vaginitis Treatment Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Vaginitis Treatment Drugs Market Size, 2017-2028
  6.5.6 India Vaginitis Treatment Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vaginitis Treatment Drugs Revenue, 2017-2028
  6.6.2 Brazil Vaginitis Treatment Drugs Market Size, 2017-2028
  6.6.3 Argentina Vaginitis Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vaginitis Treatment Drugs Revenue, 2017-2028
  6.7.2 Turkey Vaginitis Treatment Drugs Market Size, 2017-2028
  6.7.3 Israel Vaginitis Treatment Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Vaginitis Treatment Drugs Market Size, 2017-2028
  6.7.5 UAE Vaginitis Treatment Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Corporate Summary
  7.1.2 Pfizer Inc. Business Overview
  7.1.3 Pfizer Inc. Vaginitis Treatment Drugs Major Product Offerings
  7.1.4 Pfizer Inc. Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Inc. Key News
7.2 Mylan NV
  7.2.1 Mylan NV Corporate Summary
  7.2.2 Mylan NV Business Overview
  7.2.3 Mylan NV Vaginitis Treatment Drugs Major Product Offerings
  7.2.4 Mylan NV Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.2.5 Mylan NV Key News
7.3 Novartis AS
  7.3.1 Novartis AS Corporate Summary
  7.3.2 Novartis AS Business Overview
  7.3.3 Novartis AS Vaginitis Treatment Drugs Major Product Offerings
  7.3.4 Novartis AS Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.3.5 Novartis AS Key News
7.4 Bayer AG
  7.4.1 Bayer AG Corporate Summary
  7.4.2 Bayer AG Business Overview
  7.4.3 Bayer AG Vaginitis Treatment Drugs Major Product Offerings
  7.4.4 Bayer AG Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.4.5 Bayer AG Key News
7.5 Sanofi S.A.
  7.5.1 Sanofi S.A. Corporate Summary
  7.5.2 Sanofi S.A. Business Overview
  7.5.3 Sanofi S.A. Vaginitis Treatment Drugs Major Product Offerings
  7.5.4 Sanofi S.A. Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.5.5 Sanofi S.A. Key News
7.6 Lupin Pharmaceuticals, Inc.
  7.6.1 Lupin Pharmaceuticals, Inc. Corporate Summary
  7.6.2 Lupin Pharmaceuticals, Inc. Business Overview
  7.6.3 Lupin Pharmaceuticals, Inc. Vaginitis Treatment Drugs Major Product Offerings
  7.6.4 Lupin Pharmaceuticals, Inc. Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.6.5 Lupin Pharmaceuticals, Inc. Key News
7.7 Dr. Reddy's Laboratories Ltd
  7.7.1 Dr. Reddy's Laboratories Ltd Corporate Summary
  7.7.2 Dr. Reddy's Laboratories Ltd Business Overview
  7.7.3 Dr. Reddy's Laboratories Ltd Vaginitis Treatment Drugs Major Product Offerings
  7.7.4 Dr. Reddy's Laboratories Ltd Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.7.5 Dr. Reddy's Laboratories Ltd Key News
7.8 Cipla Ltd.
  7.8.1 Cipla Ltd. Corporate Summary
  7.8.2 Cipla Ltd. Business Overview
  7.8.3 Cipla Ltd. Vaginitis Treatment Drugs Major Product Offerings
  7.8.4 Cipla Ltd. Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.8.5 Cipla Ltd. Key News
7.9 Sun Pharmaceutical Industries Limited
  7.9.1 Sun Pharmaceutical Industries Limited Corporate Summary
  7.9.2 Sun Pharmaceutical Industries Limited Business Overview
  7.9.3 Sun Pharmaceutical Industries Limited Vaginitis Treatment Drugs Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries Limited Vaginitis Treatment Drugs Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries Limited Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vaginitis Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Vaginitis Treatment Drugs Market Drivers in Global Market
Table 3. Vaginitis Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Vaginitis Treatment Drugs in Global Market
Table 5. Top Vaginitis Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vaginitis Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vaginitis Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vaginitis Treatment Drugs Product Type
Table 9. List of Global Tier 1 Vaginitis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaginitis Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vaginitis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vaginitis Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vaginitis Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vaginitis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vaginitis Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vaginitis Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vaginitis Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vaginitis Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vaginitis Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vaginitis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vaginitis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vaginitis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vaginitis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vaginitis Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Vaginitis Treatment Drugs Product Offerings
Table 32. Pfizer Inc. Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Mylan NV Corporate Summary
Table 34. Mylan NV Vaginitis Treatment Drugs Product Offerings
Table 35. Mylan NV Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AS Corporate Summary
Table 37. Novartis AS Vaginitis Treatment Drugs Product Offerings
Table 38. Novartis AS Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bayer AG Corporate Summary
Table 40. Bayer AG Vaginitis Treatment Drugs Product Offerings
Table 41. Bayer AG Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi S.A. Corporate Summary
Table 43. Sanofi S.A. Vaginitis Treatment Drugs Product Offerings
Table 44. Sanofi S.A. Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Lupin Pharmaceuticals, Inc. Corporate Summary
Table 46. Lupin Pharmaceuticals, Inc. Vaginitis Treatment Drugs Product Offerings
Table 47. Lupin Pharmaceuticals, Inc. Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Dr. Reddy's Laboratories Ltd Corporate Summary
Table 49. Dr. Reddy's Laboratories Ltd Vaginitis Treatment Drugs Product Offerings
Table 50. Dr. Reddy's Laboratories Ltd Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Cipla Ltd. Corporate Summary
Table 52. Cipla Ltd. Vaginitis Treatment Drugs Product Offerings
Table 53. Cipla Ltd. Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries Limited Corporate Summary
Table 55. Sun Pharmaceutical Industries Limited Vaginitis Treatment Drugs Product Offerings
Table 56. Sun Pharmaceutical Industries Limited Vaginitis Treatment Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vaginitis Treatment Drugs Segment by Type in 2021
Figure 2. Vaginitis Treatment Drugs Segment by Application in 2021
Figure 3. Global Vaginitis Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vaginitis Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vaginitis Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaginitis Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vaginitis Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vaginitis Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc. Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan NV Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AS Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer AG Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi S.A. Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lupin Pharmaceuticals, Inc. Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dr. Reddy's Laboratories Ltd Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cipla Ltd. Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries Limited Vaginitis Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)